Injectable pre exposure therapy
In August 2025, Brazil acquired accessibility, in the economic sector, towards the very initial type of long-acting pre-exposure prophylaxis (PrEP) versus the HIV infection in the nation, provided intramuscularly every 2 months. This compound is actually cabotegravir , authorized through Anvisa in 2023. Injectable pre exposure therapy Initially glimpse, it might look like simply one more medicine choice. However community health and wellness as well as contagious illness professionals, the prospective effect is actually a lot higher. Cabotegravir might usher in a brand-new stage of HIV avoidance through resolving among the most significant traffic jams in the dental PrEP technique: adherence problems. Research researches reveal that forgetfulness, preconception, as well as logistical problems considerably decrease adherence. In some essential groups—such as guys that make love along with guys, sex employees, as well as youthful people—adherence prices hover about 50% towards 60%. ...